Annual ROE
-43.04%
-4.28%-11.04%
December 31, 2023
Summary
- As of February 7, 2025, IKNA annual return on equity is -43.04%, with the most recent change of -4.28% (-11.04%) on December 31, 2023.
- During the last 3 years, IKNA annual ROE has fallen by -86.84% (-198.26%).
- IKNA annual ROE is now -198.26% below its all-time high of 43.80%, reached on December 31, 2020.
Performance
IKNA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-39.59%
+3.22%+7.52%
September 30, 2024
Summary
- As of February 7, 2025, IKNA quarterly return on equity is -39.59%, with the most recent change of +3.22% (+7.52%) on September 30, 2024.
- Over the past year, IKNA quarterly ROE has increased by +2.10% (+5.04%).
- IKNA quarterly ROE is now -190.39% below its all-time high of 43.80%, reached on December 31, 2020.
Performance
IKNA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
IKNA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.0% | +5.0% |
| 3 y3 years | -198.3% | +2.6% |
| 5 y5 years | -257.3% | +2.6% |
IKNA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.0% | +32.6% | -101.3% | +11.3% |
| 5 y | 5-year | -198.3% | +32.6% | -190.4% | +46.7% |
| alltime | all time | -198.3% | +32.6% | -190.4% | +46.7% |
Ikena Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -39.59%(-7.5%) |
| Jun 2024 | - | -42.81%(-2.7%) |
| Mar 2024 | - | -44.00%(-1.4%) |
| Dec 2023 | -43.04%(+11.0%) | -44.62%(+7.0%) |
| Sep 2023 | - | -41.69%(+2.5%) |
| Jun 2023 | - | -40.66%(-0.7%) |
| Mar 2023 | - | -40.93%(+4.9%) |
| Dec 2022 | -38.76% | -39.03%(+41.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -27.67%(+12.3%) |
| Jun 2022 | - | -24.65%(+25.3%) |
| Mar 2022 | - | -19.67%(-13.0%) |
| Dec 2021 | -63.87%(-245.8%) | -22.62%(-51.0%) |
| Sep 2021 | - | -46.12%(-3.6%) |
| Jun 2021 | - | -47.84%(-35.6%) |
| Mar 2021 | - | -74.29%(-269.6%) |
| Dec 2020 | 43.80%(+60.1%) | 43.80% |
| Dec 2019 | 27.36% | - |
FAQ
- What is Ikena Oncology annual return on equity?
- What is the all time high annual ROE for Ikena Oncology?
- What is Ikena Oncology annual ROE year-on-year change?
- What is Ikena Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Ikena Oncology?
- What is Ikena Oncology quarterly ROE year-on-year change?
What is Ikena Oncology annual return on equity?
The current annual ROE of IKNA is -43.04%
What is the all time high annual ROE for Ikena Oncology?
Ikena Oncology all-time high annual return on equity is 43.80%
What is Ikena Oncology annual ROE year-on-year change?
Over the past year, IKNA annual return on equity has changed by -4.28% (-11.04%)
What is Ikena Oncology quarterly return on equity?
The current quarterly ROE of IKNA is -39.59%
What is the all time high quarterly ROE for Ikena Oncology?
Ikena Oncology all-time high quarterly return on equity is 43.80%
What is Ikena Oncology quarterly ROE year-on-year change?
Over the past year, IKNA quarterly return on equity has changed by +2.10% (+5.04%)